In Pursuit of COVID-19 Treatment Strategies: Are We Triggering Antimicrobial Resistance?
作者信息
Hashmi Furqan Khurshid, Atif Naveel, Malik Usman Rashid, Saleem Fahad, Riboua Zineb, Hassali Mohamed Azmi, Butt Muhammad Hammad, Mallhi Tauqeer Hussain, Khan Yusra Habib
机构信息
Punjab University College of Pharmacy, University of the Punjab, Allama Iqbal Campus, Lahore, Pakistan.
Center of Drug Safety and Policy Research, School of Pharmacy, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
出版信息
Disaster Med Public Health Prep. 2022 Aug;16(4):1285-1286. doi: 10.1017/dmp.2020.492. Epub 2020 Dec 22.
Abstract
摘要
相似文献
1
In Pursuit of COVID-19 Treatment Strategies: Are We Triggering Antimicrobial Resistance?寻求新冠治疗策略：我们是否正在引发抗菌素耐药性？
Disaster Med Public Health Prep. 2022 Aug;16(4):1285-1286. doi: 10.1017/dmp.2020.492. Epub 2020 Dec 22.
2
Azithromycin Use in COVID-19 Patients: Implications on the Antimicrobial Resistance.阿奇霉素在新冠肺炎患者中的应用：对抗菌药物耐药性的影响
Curr Top Med Chem. 2021;21(8):677-683. doi: 10.2174/156802662108210319145317.
3
Has There Been Exacerbation of Disparities in Antimicrobial Resistance during the SARS-Cov-2 Pandemic?在新冠疫情期间，抗菌药物耐药性的差异是否加剧了？
Surg Infect (Larchmt). 2022 Sep;23(7):613-615. doi: 10.1089/sur.2022.099. Epub 2022 Jul 28.
4
Editorial: Antimicrobial resistance and stewardship in the COVID-19 era.社论：新冠疫情时代的抗菌药物耐药性与管理
Front Public Health. 2024 May 1;12:1398981. doi: 10.3389/fpubh.2024.1398981. eCollection 2024.
5
Post COVID Antimicrobial Resistance Threat in Lower- and Middle-Income Countries: Bangladesh.低收入和中等收入国家（以孟加拉国为例）新冠疫情后抗菌药物耐药性威胁
Front Public Health. 2021 Dec 17;9:770593. doi: 10.3389/fpubh.2021.770593. eCollection 2021.
6
Treatment of COVID-19: implications for antimicrobial resistance in Africa.2019冠状病毒病的治疗：对非洲抗菌药物耐药性的影响
Pan Afr Med J. 2020 Jul 20;35(Suppl 2):119. doi: 10.11604/pamj.supp.2020.35.23713. eCollection 2020.
7
Non-viral infections and antimicrobial resistance in the time of COVID-19: what to expect?新冠疫情期间的非病毒感染与抗菌药物耐药性：未来会怎样？
Expert Rev Clin Pharmacol. 2022 Aug;15(8):907-909. doi: 10.1080/17512433.2022.2108403. Epub 2022 Aug 3.
8
Combating antimicrobial resistance during the COVID-19 pandemic.在新冠疫情期间对抗抗菌药物耐药性
Hong Kong Med J. 2021 Dec;27(6):396-398. doi: 10.12809/hkmj215124. Epub 2021 Nov 17.
9
The emerging antimicrobial resistance crisis during the COVID-19 surge in China.中国新冠疫情激增期间出现的抗菌药物耐药性危机。
Lancet Microbe. 2023 May;4(5):e290-e291. doi: 10.1016/S2666-5247(23)00038-1. Epub 2023 Feb 10.
10
Antimicrobial resistance vs COVID-19: A bigger challenge in the post-pandemic era!抗微生物药物耐药性与新冠疫情：大流行后时代的一项更大挑战！
J Formos Med Assoc. 2021 Jul;120(7):1537-1538. doi: 10.1016/j.jfma.2021.03.003. Epub 2021 Mar 14.
引用本文的文献
1
Hospital Pharmacists' Viewpoint on Quality Use of Antibiotics and Resistance: A Qualitative Exploration from a Tertiary Care Hospital of Quetta City, Pakistan.医院药剂师对抗生素合理使用及耐药性的观点：来自巴基斯坦奎达市一家三级护理医院的定性探索
Antibiotics (Basel). 2023 Aug 21;12(8):1343. doi: 10.3390/antibiotics12081343.
2
Increasing Consumption of Antibiotics during the COVID-19 Pandemic: Implications for Patient Health and Emerging Anti-Microbial Resistance.新冠疫情期间抗生素使用量增加：对患者健康及新出现的抗菌药物耐药性的影响
Antibiotics (Basel). 2022 Dec 28;12(1):45. doi: 10.3390/antibiotics12010045.
3
War against COVID-19: looming threat of XDR typhoid battle in Pakistan.抗击新冠疫情：巴基斯坦面临广泛耐药伤寒杆菌之战的潜在威胁。
Public Health. 2021 Sep;198:e15-e16. doi: 10.1016/j.puhe.2021.05.019. Epub 2021 May 21.
4
Knowledge, Attitude, and Practices (KAPs) of Community Pharmacists Regarding COVID-19: A Cross-Sectional Survey in 2 Provinces of Pakistan.社区药剂师对 COVID-19 的知识、态度和实践（KAP）：巴基斯坦两省的横断面调查。
Disaster Med Public Health Prep. 2022 Oct;16(5):1864-1872. doi: 10.1017/dmp.2021.54. Epub 2021 Feb 16.
Zotero 插件